Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24127236)

1.

Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk.

Lee ST, Bracci P, Zhou M, Rice T, Wiencke J, Wrensch M, Wiemels J.

Int J Cancer. 2014 May 1;134(9):2199-210. doi: 10.1002/ijc.28535. Epub 2013 Oct 31.

PMID:
24127236
2.

History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.

Wrensch M, Weinberg A, Wiencke J, Miike R, Sison J, Wiemels J, Barger G, DeLorenze G, Aldape K, Kelsey K.

Am J Epidemiol. 2005 May 15;161(10):929-38.

3.

Does prior infection with varicella-zoster virus influence risk of adult glioma?

Wrensch M, Weinberg A, Wiencke J, Masters H, Miike R, Barger G, Lee M.

Am J Epidemiol. 1997 Apr 1;145(7):594-7.

4.

Prevalence of antibodies to four herpesviruses among adults with glioma and controls.

Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K.

Am J Epidemiol. 2001 Jul 15;154(2):161-5.

5.

Human immunoglobulin G levels of viruses and associated glioma risk.

Sjöström S, Hjalmars U, Juto P, Wadell G, Hallmans G, Tjönneland A, Halkjaer J, Manjer J, Almquist M, Melin BS.

Cancer Causes Control. 2011 Sep;22(9):1259-66. doi: 10.1007/s10552-011-9799-3. Epub 2011 Jun 30.

6.
8.

Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.

Prelog M, Schönlaub J, Jeller V, Almanzar G, Höfner K, Gruber S, Eiwegger T, Würzner R.

Vaccine. 2013 May 7;31(20):2420-6. doi: 10.1016/j.vaccine.2013.03.058. Epub 2013 Apr 10.

PMID:
23583889
9.

A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens.

Vizoso Pinto MG, Pfrepper KI, Janke T, Noelting C, Sander M, Lueking A, Haas J, Nitschko H, Jaeger G, Baiker A.

Virol J. 2010 Jul 20;7:165. doi: 10.1186/1743-422X-7-165.

10.

Antibody to early antigens of varicella-zoster virus during varicella and zoster.

Gerna G, Cereda PM, Cattaneo E, Achilli G, Gerna MT.

J Infect Dis. 1979 Jul;140(1):33-41.

PMID:
88490
11.

A relationship between varicella-zoster virus-specific delayed hypersensitivity and varicella-zoster virus-induced anterior uveitis.

Kezuka T, Sakai J, Minoda H, Takeuchi M, Keino H, Streilein JW, Usui M.

Arch Ophthalmol. 2002 Sep;120(9):1183-8.

PMID:
12215092
15.

Susceptibility to varicella-zoster virus in applicants for nurse training in Scotland.

Waclawski ER, Stewart M.

Commun Dis Public Health. 2002 Sep;5(3):240-2.

PMID:
12434695
16.

Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.

Haumont M, Jurdan M, Kangro H, Jacquet A, Massaer M, Deleersnyder V, Garcia L, Bosseloir A, Bruck C, Bollen A, Jacobs P.

J Med Virol. 1997 Sep;53(1):63-8.

PMID:
9298734
17.

Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.

Jacquet A, Haumont M, Massaer M, Garcia L, Mazzu P, Daminet V, Grégoire D, Jacobs P, Bollen A.

Vaccine. 2002 Feb 22;20(11-12):1593-602.

PMID:
11858867
18.
20.

Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.

Meyer C, Engelmann F, Arnold N, Krah DL, ter Meulen J, Haberthur K, Dewane J, Messaoudi I.

J Virol. 2015 Feb;89(3):1781-93. doi: 10.1128/JVI.03124-14. Epub 2014 Nov 19.

PMID:
25410871
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk